Published in J Biol Chem on October 16, 1998
Partial restoration of mutant enzyme homeostasis in three distinct lysosomal storage disease cell lines by altering calcium homeostasis. PLoS Biol (2008) 1.42
Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain. Biochem J (2000) 1.06
Inactivation determinants in segment IIIS6 of Ca(v)3.1. J Physiol (2001) 1.02
Molecular pharmacology of high voltage-activated calcium channels. J Bioenerg Biomembr (2003) 0.97
High affinity interaction of mibefradil with voltage-gated calcium and sodium channels. Br J Pharmacol (2000) 0.97
Ca2+ channel-sarcoplasmic reticulum coupling: a mechanism of arterial myocyte contraction without Ca2+ influx. EMBO J (2003) 0.96
Alternative splicing modulates diltiazem sensitivity of cardiac and vascular smooth muscle Ca(v)1.2 calcium channels. Br J Pharmacol (2010) 0.95
Mouse Grueneberg ganglion neurons share molecular and functional features with C. elegans amphid neurons. Front Behav Neurosci (2013) 0.92
Ion selectivity filter regulates local anesthetic inhibition of G-protein-gated inwardly rectifying K+ channels. Biophys J (2001) 0.85
Role of transient receptor potential channels in cholecystokinin-induced activation of cultured vagal afferent neurons. Endocrinology (2010) 0.84
Interaction of diltiazem with an intracellularly accessible binding site on Ca(V)1.2. Br J Pharmacol (2011) 0.75
Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels. Cell (2000) 5.08
Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci U S A (1996) 3.39
alpha 1D (Cav1.3) subunits can form l-type Ca2+ channels activating at negative voltages. J Biol Chem (2001) 2.77
Functional embryonic cardiomyocytes after disruption of the L-type alpha1C (Cav1.2) calcium channel gene in the mouse. J Biol Chem (2000) 2.09
The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology (2011) 2.06
Use of X-linked markers for forensic purposes. Int J Legal Med (2003) 1.91
Receptor sites for Ca2+ channel antagonists. Trends Pharmacol Sci (1992) 1.84
Fast exocytosis with few Ca(2+) channels in insulin-secreting mouse pancreatic B cells. Biophys J (2001) 1.79
Structural basis of drug binding to L Ca2+ channels. Trends Pharmacol Sci (1998) 1.69
Visualization of the domain structure of an L-type Ca2+ channel using electron cryo-microscopy. J Mol Biol (2003) 1.56
Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels. Neuron (1996) 1.46
Current modulation and membrane targeting of the calcium channel alpha1C subunit are independent functions of the beta subunit. J Physiol (1999) 1.45
16 X-chromosome STR loci frequency data from a German population. Forensic Sci Int (2001) 1.44
Familial hemiplegic migraine mutations change alpha1A Ca2+ channel kinetics. J Biol Chem (1998) 1.44
Molecular properties of calcium channels. Rev Physiol Biochem Pharmacol (1990) 1.44
Excitation-contraction coupling is unaffected by drastic alteration of the sequence surrounding residues L720-L764 of the alpha 1S II-III loop. Proc Natl Acad Sci U S A (2001) 1.37
Pharmacological properties of GABAA receptors containing gamma1 subunits. Mol Pharmacol (2005) 1.32
The triad targeting signal of the skeletal muscle calcium channel is localized in the COOH terminus of the alpha(1S) subunit. J Cell Biol (2000) 1.32
Endogenous calcium channels in human embryonic kidney (HEK293) cells. Br J Pharmacol (1996) 1.31
Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine. Proc Natl Acad Sci U S A (1991) 1.31
Automated fast perfusion of Xenopus oocytes for drug screening. Pflugers Arch (2006) 1.30
Purified skeletal muscle 1,4-dihydropyridine receptor forms phosphorylation-dependent oligomeric calcium channels in planar bilayers. Proc Natl Acad Sci U S A (1988) 1.28
Beta subunit heterogeneity in neuronal L-type Ca2+ channels. J Biol Chem (1997) 1.27
State dependent dissociation of HERG channel inhibitors. Br J Pharmacol (2007) 1.27
The action of caffeine on inward barium current through voltage-dependent calcium channels in single rabbit ear artery cells. Pflugers Arch (1990) 1.25
Identification of a novel 1,4-dihydropyridine- and phenylalkylamine-binding polypeptide in calcium channel preparations. J Biol Chem (1987) 1.25
Down-regulation of L-type calcium channels in inflamed circular smooth muscle cells of the canine colon. Gastroenterology (2001) 1.18
Calcium channels from Cyprinus carpio skeletal muscle. Proc Natl Acad Sci U S A (1991) 1.17
Valerenic acid potentiates and inhibits GABA(A) receptors: molecular mechanism and subunit specificity. Neuropharmacology (2007) 1.15
Characterization of the fast sodium current in isolated rat myocardial cells: simulation of the clamped membrane potential. J Physiol (1982) 1.14
Immortalization and transformation of human fibroblasts by regulated expression of polyoma virus T antigens. Oncogene (1990) 1.14
Photoaffinity labelling of the phenylalkylamine receptor of the skeletal muscle transverse-tubule calcium channel. FEBS Lett (1987) 1.13
Neurological phenotype and synaptic function in mice lacking the CaV1.3 alpha subunit of neuronal L-type voltage-dependent Ca2+ channels. Neuroscience (2003) 1.13
L-type calcium channels in insulin-secreting cells: biochemical characterization and phosphorylation in RINm5F cells. Mol Endocrinol (1997) 1.12
Three new familial hemiplegic migraine mutants affect P/Q-type Ca(2+) channel kinetics. J Biol Chem (2000) 1.12
Stereoselective photoaffinity labelling of the purified 1,4-dihydropyridine receptor of the voltage-dependent calcium channel. Eur J Biochem (1986) 1.12
Phenylalkylamine Ca2+ antagonist binding protein. Molecular cloning, tissue distribution, and heterologous expression. J Biol Chem (1995) 1.12
(-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle. FEBS Lett (1984) 1.11
Identification of PK-A phosphorylation sites in the carboxyl terminus of L-type calcium channel alpha 1 subunits. Biochemistry (1996) 1.11
Transfer of high sensitivity for benzothiazepines from L-type to class A (BI) calcium channels. J Biol Chem (1996) 1.10
Analysis of membrane protein self-association in lipid systems by fluorescence particle counting: application to the dihydropyridine receptor. Biochemistry (1997) 1.08
The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis. Trends Pharmacol Sci (1997) 1.07
Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain. Biochem J (2000) 1.06
Modulation of slow inactivation in class A Ca2+ channels by beta-subunits. J Physiol (2000) 1.04
Apolipoprotein AI and transthyretin as components of amyloid fibrils in a kindred with apoAI Leu178His amyloidosis. Am J Pathol (2000) 1.03
Inactivation determinants in segment IIIS6 of Ca(v)3.1. J Physiol (2001) 1.02
Nine L-type amino acid residues confer full 1,4-dihydropyridine sensitivity to the neuronal calcium channel alpha1A subunit. Role of L-type Met1188. J Biol Chem (1997) 1.02
Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the sigma 1 binding site by photoaffinity labeling and ligand-directed antibodies. Mol Pharmacol (1993) 1.02
Up-regulation of dopamine D(2)L mRNA levels in the ventral tegmental area and dorsal striatum of amphetamine-sensitized C57BL/6 mice: role of Ca(v)1.3 L-type Ca(2+) channels. J Neurochem (2006) 1.01
Molecular mechanism of use-dependent calcium channel block by phenylalkylamines: role of inactivation. Proc Natl Acad Sci U S A (1997) 1.00
Valerenic acid derivatives as novel subunit-selective GABAA receptor ligands - in vitro and in vivo characterization. Br J Pharmacol (2010) 0.99
Sodium and calcium currents in neuroblastoma x glioma hybrid cells before and after morphological differentiation by dibutyryl cyclic AMP. Gen Physiol Biophys (1985) 0.99
Brain activation pattern induced by stimulation of L-type Ca2+-channels: contribution of Ca(V)1.3 and Ca(V)1.2 isoforms. Neuroscience (2006) 0.98
High affinity interaction of mibefradil with voltage-gated calcium and sodium channels. Br J Pharmacol (2000) 0.97
A light stabilizer (Tinuvin 770) that elutes from polypropylene plastic tubes is a potent L-type Ca(2+)-channel blocker. Proc Natl Acad Sci U S A (1993) 0.97
Calcium channels and calcium channel drugs: recent biochemical and biophysical findings. Arzneimittelforschung (1985) 0.96
Quantification of ankle articular cartilage topography and thickness using a high resolution stereophotography system. Osteoarthritis Cartilage (2006) 0.96
Insect calcium channels. Molecular cloning of an alpha 1-subunit from housefly (Musca domestica) muscle. FEBS Lett (1994) 0.96
Block of P/Q-type calcium channels by therapeutic concentrations of aminoglycoside antibiotics. Biochemistry (1996) 0.96
Neurotoxic aminoglycoside antibiotics are potent inhibitors of [125I]-Omega-Conotoxin GVIA binding to guinea-pig cerebral cortex membranes. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.95
Two amino acid residues in the IIIS5 segment of L-type calcium channels differentially contribute to 1,4-dihydropyridine sensitivity. J Biol Chem (1996) 0.95
Calcium channels. Vitam Horm (1988) 0.95
Calcium channels: the beta-subunit increases the affinity of dihydropyridine and Ca2+ binding sites of the alpha 1-subunit. FEBS Lett (1994) 0.94
Coordination of Ca2+ by the pore region glutamates is essential for high-affinity dihydropyridine binding to the cardiac Ca2+ channel alpha 1 subunit. Biochemistry (1995) 0.94
Purified calcium channels have three allosterically coupled drug receptors. FEBS Lett (1986) 0.93
Potentiation of the cardiac L-type Ca(2+) channel (alpha(1C)) by dihydropyridine agonist and strong depolarization occur via distinct mechanisms. J Gen Physiol (2001) 0.93
Molecular mechanism of calcium channel block by isradipine. Role of a drug-induced inactivated channel conformation. J Biol Chem (2000) 0.92
Insertion of the full-length calcium channel alpha(1S) subunit into triads of skeletal muscle in vitro. FEBS Lett (2000) 0.91
Air quality measurements from the Fresno Supersite. J Air Waste Manag Assoc (2000) 0.91
Biochemical characterization of a 22-kDa high affinity antiischemic drug-binding polypeptide in the endoplasmic reticulum of guinea pig liver: potential common target for antiischemic drug action. Mol Pharmacol (1993) 0.91
Targeting voltage-gated Ca2+ channels. Lancet (2001) 0.90
Human red-blood-cell Ca2+-antagonist binding sites. Evidence for an unusual receptor coupled to the nucleoside transporter. Eur J Biochem (1985) 0.90
Sequence differences between alpha1C and alpha1S Ca2+ channel subunits reveal structural determinants of a guarded and modulated benzothiazepine receptor. J Biol Chem (1999) 0.90
Extra- and intracellular action of quaternary devapamil on muscle L-type Ca(2+)-channels. Br J Pharmacol (1996) 0.90
Trapping and dissociation of propafenone derivatives in HERG channels. Br J Pharmacol (2011) 0.90
beta subunit heterogeneity of L-type Ca(2+) channels in smooth muscle tissues. FEBS Lett (2000) 0.90
Amino acids in segment IVS6 and beta-subunit interaction support distinct conformational changes during Ca(v)2.1 inactivation. J Biol Chem (2001) 0.88
Transfer of L-type calcium channel IVS6 segment increases phenylalkylamine sensitivity of alpha1A. J Biol Chem (1996) 0.88
Presence of regulatory sequences within intron 2 of the mouse thymidine kinase gene. Nucleic Acids Res (1991) 0.88
Purification and amino-terminal sequencing of the high affinity phenylalkylamine Ca2+ antagonist binding protein from guinea pig liver endoplasmic reticulum. J Biol Chem (1994) 0.88